Elsevier

Clinical Therapeutics

Volume 26, Issue 8, August 2004, Pages 1305-1318
Clinical Therapeutics

French guidelines for the diagnosis and management of migraine in adults and children

https://doi.org/10.1016/S0149-2918(04)80161-9Get rights and content

Abstract

Background

The French Recommendations for Clinical Practice: Diagnosis and Therapy of Migraine are guidelines concerning the overall management of patients with migraine, including diagnostic and therapeutic strategies and assessment of disability.

Objective

This article summarizes the guidelines as they apply to adults and children, and proposes future direction for steps toward optimal treatment of migraine in patients in France.

Methods

The recommendations were categorized into 3 levels of proof (A—C) according to the National Agency for Accreditation and Evaluation in Health (ANAES) methodology and were based on a professional consensus reached among members of the Working Group and the Guidelines Review Group of the ANAES.

Results

The International Headache Society diagnostic criteria for migraine should be used in routine clinical practice. Recommended agents for the treatment of migraine in adults include nonsteroidal anti-inflammatory drugs, acetylsalicylic acid (ASA) monotherapy or in combination with metoclopramide, acetaminophen monotherapy, triptans, ergotamine tartrate, and dihydroergotamine mesylate. Patients should use the medication as early as possible after the onset of migraine headache. For migraine prophylaxis in adults, the following can be used: propranolol, metoprolol, oxetorone, or amitriptyline as first-line treatment, and pizotifen, flunarizine, valproate sodium, or topiramate as second-line treatment. Migraine in children can be distinguished from that in adults by shorter duration (2–48 hours in children aged <15 years), more frequent bilateral localization, frequent predominant gastrointestinal disturbances, and frequent pallor hailing the onset of the attack. The following drugs are recommended in children and adolescents: ibuprofen in children aged >6 months, diclofenac in children weighing >16 kg, naproxen in children aged >6 years or weighing >25 kg, ASA alone or in combination with metoclopramide, acetaminophen alone or in combination with metoclopramide, and ergotamine tartrate in children aged >10 years.

Conclusions

These guidelines are intended to help general practitioners to manage migraine patients according to the rules of evidence-based medicine.

References (59)

  • RussellMB et al.

    A nosographic analysis of the migraine aura in a general population

    Brain

    (1996)
  • LeoneM et al.

    Assessment of International Headache Society diagnostic criteria: A reliability study

    Cephalalgia

    (1994)
  • RasmussenBK et al.

    A population-based analysis of the diagnostic criteria of the International Headache Society

    Cephalalgia

    (1991)
  • MichelP et al.

    Validity of the International Headache Society criteria for migraine

    Neuroepidemiology

    (1993)
  • RasmussenBK et al.

    Interrelations between migraine and tension-type headache in the general population

    Arch Neurol

    (1992)
  • De BenedittisG et al.

    Magnetic resonance imaging in migraine and tension-type headache

    Headache

    (1995)
  • GronsethGS et al.

    The utility of the electroencephalogram in the evaluation of patients presenting with headache: A review of the literature

    Neurology

    (1995)
  • HenryP et al.

    A nationwide survey of migraine in France: Prevalence and clinical features in adults

    Cephalalgia

    (1992)
  • MerikangasKR et al.

    Migraine and psychopathology

    Results of the Zurich cohort study of young adults

    Arch Gen Psychiatry

    (1990)
  • BreslauN et al.

    The impact of migraine

    Epidemiology, risk factors, and co-morbidities

    Neurology

    (2001)
  • SwartzKL et al.

    Mental disorders and the incidence of migraine headaches in a community sample: Results from the Baltimore Epidemiologic Catchment Area follow-up study

    Arch Gen Psychiatry

    (2000)
  • LeplgeA et al.

    The French SF-36 Health Survey: Translation, cultural adaptation and preliminary psychometric evaluation

    J Clin Epidemiol

    (1998)
  • MichelP et al.

    Loss of productivity and quality of life in migraine sufferers among French workers: Results from the GAZEL cohort

    Headache

    (1997)
  • RichardA et al.

    Quality of life and migraine

    Validation of the QVM Questionnaire in hospital consultation and in general medicine

    Th rapie

    (1993)
  • GandekB et al.

    Translating the Short-Form Headache Impact Test (HIT-6) in 27 countries: Methodological and conceptual issues

    Qual Life Res

    (2003)
  • Lant ri-MinetM et al.

    Prevalence and description of chronic daily headache in the general population in France

    Pain

    (2003)
  • LucasC et al.

    Therapeutic behavior of migraineurs

    FRAMIG 2000 II

    Douleurs

    (2001)
  • JohnsonES et al.

    Naproxen sodium in the treatment of migraine

    Cephalalgia

    (1985)
  • AnderssonPG et al.

    Double-blind study of naproxen vs placebo in the treatment of acute migraine attacks

    Cephalalgia

    (1989)
  • Cited by (0)

    View full text